FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 792 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR A Pet Pug Helped Two Sisters Realize They Both Had Breast... October 16, 2020 Similar Median OS Between Ripretinib versus Sunitinib in Patients with Advanced... June 2, 2025 Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers July 7, 2026 World Cancer Day 2023: where does the UK stand? February 3, 2023 Load more HOT NEWS Cancer services during COVID-19: 40,000 fewer people starting treatment Understanding the Risk of Second Cancers After CAR T-Cell Therapy Durable Responses Observed in Patients with Papillary Craniopharyngiomas Tested Positive for... What is Mindfulness?
